Back to Search
MARK KEATING, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1295704450IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD049154L(PA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Class of 1990
Research & Publications (20)
Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia.
PMID 19074592·J Mol Diagn·2009
8-other
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.
PMID 15767648·J Clin Oncol·2005
3-trial
Role of periureteral injections in children with vesicoureteral reflux.
PMID 16205485·Curr Opin Urol·2005
4-observational
Genetic approaches to disease and regeneration.
PMID 15293807·Philos Trans R Soc Lond B Biol Sci·2004
6-review
Biology and treatment of chronic lymphocytic leukemia.
PMID 14633781·Hematology Am Soc Hematol Educ Program·2003
6-review
Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia.
PMID 12685828·Leuk Lymphoma·2002
8-other
Management of chronic lymphocytic leukemia: a changing field.
PMID 12823777·Rev Clin Exp Hematol·2002
6-review
Identification of a key residue in the conformational stability of acyl carrier protein.
PMID 12445484·Biochim Biophys Acta·2002
4-observational
Emerging information on the use of rituximab in chronic lymphocytic leukemia.
PMID 11842391·Semin Oncol·2002
6-review
Progress in CLL, chemotherapy, antibodies and transplantation.
PMID 11769960·Biomed Pharmacother·2001
8-other
Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemia.
PMID 10721771·Leuk Lymphoma·2000
8-other
Chronic lymphocytic leukemia . Clinical oral poster session.
PMID 11036949·Hematol Cell Ther·2000
6-review
Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 Years.
PMID 19646755·Leuk Res·2010
3-trial
Healthcare-associated hepatitis C virus transmission among patients in an abdominal organ transplant center.
PMID 19497073·Transpl Infect Dis·2009
8-other
A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemia.
PMID 19637351·Cancer·2009
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1414 9TH AVE
ALTOONA, PA 16602 - Phone
- (814) 946-1655
Quick Facts
- NPI
- 1295704450
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile